NxStage Medical, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 75 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-12-31: Reporting owner Turk Joseph E Jr; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-12-29: Reporting owner Swan Winifred L; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-12-23: Reporting owner Turk Joseph E Jr; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-12-23: Reporting owner Turk Joseph E Jr; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,628 800 owned after | $4.54 exercise price | 2015-01-05 | |
| 2014-12-29 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −667 666 owned after | $6.84 exercise price | 2014-12-31 | |
| 2014-12-23 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −400 5,428 owned after | $4.54 exercise price | 2014-12-23 | |
| 2014-12-23 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 8,961 owned after | $2.11 exercise price | 2014-12-23 | |
| 2014-12-23 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −800 38,000 owned after | $9.96 exercise price | 2014-12-23 | |
| 2014-12-22 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −667 1,333 owned after | $6.84 exercise price | 2014-12-23 | |
| 2014-12-15 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,800 0 owned after | $6.84 exercise price | 2015-10-22 | |
| 2014-12-15 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 5,800 owned after | $6.84 exercise price | 2014-12-16 | |
| 2014-12-12 | Hershberger Kevin Officer (Chief Accounting Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 7,576 owned after | $9.96 exercise price | 2014-12-16 | |
| 2014-12-03 | Brown Robert S. Officer (President, Kidney Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −300 0 owned after | $14.44 exercise price | 2014-12-04 | |
| 2014-12-02 | Brown Robert S. Officer (President, Kidney Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −34,700 300 owned after | $14.44 exercise price | 2014-12-02 | |
| 2014-12-01 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,762 0 owned after | $14.44 exercise price | 2014-12-02 | |
| 2014-12-01 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,667 0 owned after | $14.44 exercise price | 2014-12-02 | |
| 2014-11-25 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 7,800 owned after | $6.84 exercise price | 2014-11-25 | |
| 2014-11-25 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −400 5,828 owned after | $4.54 exercise price | 2014-11-25 | |
| 2014-11-25 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 9,111 owned after | $2.11 exercise price | 2014-11-25 | |
| 2014-11-25 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −800 38,800 owned after | $9.96 exercise price | 2014-11-25 | |
| 2014-11-24 | Burbank Jeffrey H Director, Officer (CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −120,000 0 owned after | $14.44 exercise price | 2014-11-25 | |
| 2014-11-14 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,667 16,667 owned after | $14.44 exercise price | 2014-11-17 | |
| 2014-11-14 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,760 24,762 owned after | $14.44 exercise price | 2014-11-17 | |
| 2014-11-13 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,800 39,600 owned after | $9.96 exercise price | 2014-11-17 | |
| 2014-11-12 | Hershberger Kevin Officer (Chief Accounting Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,824 12,576 owned after | $9.96 exercise price | 2014-11-12 | |
| 2014-11-07 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,761 49,522 owned after | $14.44 exercise price | 2014-11-12 | |
| 2014-11-07 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,666 33,334 owned after | $14.44 exercise price | 2014-11-12 | |
| 2014-11-05 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,000 7,439 owned after | $9.96 exercise price | 2014-11-07 | |
| 2014-11-03 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,717 74,283 owned after | $14.44 exercise price | 2014-11-04 | |
| 2014-10-23 | Brown Robert S. Officer (President, Kidney Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −43,470 0 owned after | $4.54 exercise price | 2014-10-24 | |
| 2014-10-23 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 8,800 owned after | $6.84 exercise price | 2014-10-24 | |
| 2014-10-23 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −400 6,228 owned after | $4.54 exercise price | 2014-10-24 | |
| 2014-10-23 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 9,261 owned after | $2.11 exercise price | 2014-10-24 | |
| 2014-10-22 | Brown Robert S. Officer (President, Kidney Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,900 43,470 owned after | $4.54 exercise price | 2014-10-24 | |
| 2014-10-15 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,968 2,000 owned after | $6.84 exercise price | 2014-10-17 | |
| 2014-09-24 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 10,800 owned after | $6.84 exercise price | 2014-09-26 | |
| 2014-09-24 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −400 6,628 owned after | $4.54 exercise price | 2014-09-26 | |
| 2014-09-24 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 9,411 owned after | $2.11 exercise price | 2014-09-26 | |
| 2014-08-27 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 12,800 owned after | $6.84 exercise price | 2014-08-28 | |
| 2014-08-27 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −400 7,028 owned after | $4.54 exercise price | 2014-08-28 | |
| 2014-08-27 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 9,561 owned after | $2.11 exercise price | 2014-08-28 | |
| 2014-08-15 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 4,968 owned after | $6.84 exercise price | 2014-08-18 | |
| 2014-07-25 | Burbank Jeffrey H Director, Officer (CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −73,120 0 owned after | $6.84 exercise price | 2014-07-29 | |
| 2014-07-25 | Burbank Jeffrey H Director, Officer (CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −206,500 0 owned after | $4.54 exercise price | 2014-07-29 | |
| 2014-07-25 | Burbank Jeffrey H Director, Officer (CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,226 189,274 owned after | $2.11 exercise price | 2014-07-29 | |
| 2014-07-24 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 13,800 owned after | $6.84 exercise price | 2014-07-28 | |
| 2014-07-24 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −400 7,428 owned after | $4.54 exercise price | 2014-07-28 | |
| 2014-07-24 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 9,711 owned after | $2.11 exercise price | 2014-07-28 | |
| 2014-07-18 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 6,968 owned after | $6.84 exercise price | 2014-07-22 | |
| 2014-06-24 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 15,800 owned after | $6.84 exercise price | 2014-06-24 | |
| 2014-06-24 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −800 7,828 owned after | $4.54 exercise price | 2014-06-24 | |
| 2014-06-24 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 9,861 owned after | $2.11 exercise price | 2014-06-24 | |
| 2014-06-09 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −92 0 owned after | $4.54 exercise price | 2014-06-11 | |
| 2014-06-09 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,175 0 owned after | $2.11 exercise price | 2014-06-11 | |
| 2014-06-09 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,461 19,439 owned after | $9.96 exercise price | 2014-06-11 | |
| 2014-06-05 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 24,900 owned after | $9.96 exercise price | 2014-06-09 | |
| 2014-05-29 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 17,800 owned after | $6.84 exercise price | 2014-06-02 | |
| 2014-05-29 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −885 8,628 owned after | $4.54 exercise price | 2014-06-02 | |
| 2014-05-29 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 10,011 owned after | $2.11 exercise price | 2014-06-02 | |
| 2014-05-22 | Straube Barry M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,394 23,394 owned after | $13.16 exercise price | 2014-05-27 | |
| 2014-05-22 | Shreiner Jay W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,394 23,394 owned after | $13.16 exercise price | 2014-05-27 | |
| 2014-05-22 | Mixer Jean K Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,394 23,394 owned after | $13.16 exercise price | 2014-05-27 | |
| 2014-05-22 | REID PERPER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,394 23,394 owned after | $13.16 exercise price | 2014-05-27 | |
| 2014-05-22 | MOORE CRAIG W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,394 23,394 owned after | $13.16 exercise price | 2014-05-27 | |
| 2014-05-22 | LEWIS EARL R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,394 23,394 owned after | $13.16 exercise price | 2014-05-27 | |
| 2014-05-22 | FUNARI ROBERT G Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,394 23,394 owned after | $13.16 exercise price | 2014-05-27 | |
| 2014-05-22 | Giannini Daniel A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,394 23,394 owned after | $13.16 exercise price | 2014-05-27 | |
| 2014-05-15 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 8,968 owned after | $6.84 exercise price | 2014-05-16 | |
| 2014-05-15 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,629 92 owned after | $4.54 exercise price | 2014-05-16 | |
| 2014-05-15 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 3,175 owned after | $2.11 exercise price | 2014-05-16 | |
| 2014-03-10 | Brown Robert S. Officer (President, Kidney Care) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,958 60,958 owned after | $14.66 exercise price | 2014-03-13 | |
| 2014-03-10 | Burbank Jeffrey H Director, Officer (CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +175,256 175,256 owned after | $14.66 exercise price | 2014-03-13 | |
| 2014-03-10 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +49,529 49,529 owned after | $14.66 exercise price | 2014-03-13 | |
| 2014-03-10 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,958 60,958 owned after | $14.66 exercise price | 2014-03-13 | |
| 2014-03-10 | TOWSE MATTHEW W Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,958 60,958 owned after | $14.66 exercise price | 2014-03-13 | |
| 2014-03-10 | Hershberger Kevin Officer (Chief Accounting Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,239 15,239 owned after | $14.66 exercise price | 2014-03-13 | |
| 2014-03-05 | MOORE CRAIG W Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 0 owned after | $3.38 exercise price | 2014-03-07 | |
| 2014-01-02 | Giannini Daniel A Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 0 owned after | $3.38 exercise price | 2014-01-03 |